https://medicaldialogues.in/news/industry/pharma/dosing-schedule-and-duration-not-defined-cdsco-panel-tells-windlas-biotech-on-antihypertensive-fdc-drug-100017
0
0
Dosing schedule and duration not defined: CDSCO panel tells Windlas Biotech on antihypertensive FDC Drug - Medical Dialogues
10/1/22 at 11:30am
Organization
Medical Dialogues
Author
Medical Dialogues Team
32 words
0
Comments
New Delhi: Citing that dosing schedule and duration was not defined, the Subject Expert Committee...
You are the first to view
Create an account or login to join the discussion